Exchange: NASDAQ·Updated 11:36 AM EDT
ENSC logo

ENSC Ensysce Biosciences Inc

$0.3928
$0.0071
(1.77%)
Today
Reported EarningsMay 13
Mkt Cap$81.69M
Vol371,351.00

About ENSC

Leisure Acquisition Corp. operates as a blank check company. It operates for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 11, 2017 and is headquartered in New York, NY.
37

Bearish Sentiment

How do you feel about ENSC?

Community Summary

Ensysce Biosciences investors are intensely debating the company's compliance status following Nasdaq granting a second 180-day grace period, while heavily discussing the recent Cy Biopharma acquisition, insider buying by Chairman Bob Gower, financing dilution risks, and upcoming clinical catalysts amid sharp divisions between bullish and bearish sentiments.

Last updated: 6h agoAI generated, may contain errors

Advertisement|Remove ads.